Checkpoint Cash Per Share vs Cash Flow To Debt Ratio Analysis

CKPT Stock  USD 3.93  0.04  1.01%   
Checkpoint Therapeutics financial indicator trend analysis is way more than just evaluating Checkpoint Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Checkpoint Therapeutics is a good investment. Please check the relationship between Checkpoint Therapeutics Cash Per Share and its Cash Flow To Debt Ratio accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Checkpoint Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more information on how to buy Checkpoint Stock please use our How to Invest in Checkpoint Therapeutics guide.

Cash Per Share vs Cash Flow To Debt Ratio

Cash Per Share vs Cash Flow To Debt Ratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Checkpoint Therapeutics Cash Per Share account and Cash Flow To Debt Ratio. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Checkpoint Therapeutics' Cash Per Share and Cash Flow To Debt Ratio is -0.56. Overlapping area represents the amount of variation of Cash Per Share that can explain the historical movement of Cash Flow To Debt Ratio in the same time period over historical financial statements of Checkpoint Therapeutics, assuming nothing else is changed. The correlation between historical values of Checkpoint Therapeutics' Cash Per Share and Cash Flow To Debt Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash Per Share of Checkpoint Therapeutics are associated (or correlated) with its Cash Flow To Debt Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash Flow To Debt Ratio has no effect on the direction of Cash Per Share i.e., Checkpoint Therapeutics' Cash Per Share and Cash Flow To Debt Ratio go up and down completely randomly.

Correlation Coefficient

-0.56
Relationship DirectionNegative 
Relationship StrengthVery Weak

Cash Per Share

Cash Flow To Debt Ratio

Most indicators from Checkpoint Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Checkpoint Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Checkpoint Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more information on how to buy Checkpoint Stock please use our How to Invest in Checkpoint Therapeutics guide.Sales General And Administrative To Revenue is likely to gain to 88.54 in 2024, whereas Selling General Administrative is likely to drop slightly above 7.3 M in 2024.
 2021 2022 2023 2024 (projected)
Depreciation And Amortization53K4.5M167.9K159.5K
Interest Income53K160K154K102.1K

Checkpoint Therapeutics fundamental ratios Correlations

0.10.280.860.73-0.120.441.00.220.31-0.38-0.610.680.460.350.310.631.00.630.750.26-0.170.130.260.330.27
0.10.95-0.390.47-0.830.680.1-0.120.79-0.840.30.530.380.850.940.530.10.530.27-0.250.57-0.59-0.250.720.87
0.280.95-0.240.5-0.830.880.270.070.83-0.90.180.630.490.871.00.630.280.630.48-0.230.52-0.55-0.230.730.88
0.86-0.39-0.240.460.34-0.010.870.19-0.140.1-0.740.350.22-0.11-0.210.290.860.290.510.43-0.460.440.43-0.03-0.18
0.730.470.50.46-0.570.410.740.040.67-0.65-0.120.860.350.690.540.850.730.850.58-0.240.34-0.36-0.240.270.56
-0.12-0.83-0.830.34-0.57-0.67-0.110.07-0.980.94-0.52-0.66-0.39-0.93-0.83-0.71-0.12-0.71-0.510.66-0.740.760.66-0.37-0.89
0.440.680.88-0.010.41-0.670.420.390.71-0.8-0.040.670.610.720.880.660.440.660.64-0.160.42-0.45-0.160.540.7
1.00.10.270.870.74-0.110.420.190.31-0.37-0.60.670.430.340.30.621.00.620.740.26-0.190.150.260.330.26
0.22-0.120.070.190.040.070.390.19-0.030.01-0.440.340.29-0.010.070.310.220.310.130.120.25-0.260.12-0.28-0.12
0.310.790.83-0.140.67-0.980.710.31-0.03-0.980.370.760.480.940.830.810.310.810.67-0.60.68-0.7-0.60.410.89
-0.38-0.84-0.90.1-0.650.94-0.8-0.370.01-0.98-0.26-0.76-0.57-0.96-0.9-0.79-0.38-0.79-0.70.44-0.60.630.44-0.55-0.93
-0.610.30.18-0.74-0.12-0.52-0.04-0.6-0.440.37-0.26-0.23-0.370.270.17-0.12-0.61-0.12-0.19-0.770.34-0.32-0.77-0.060.34
0.680.530.630.350.86-0.660.670.670.340.76-0.76-0.230.650.780.650.990.680.990.71-0.230.6-0.63-0.230.20.63
0.460.380.490.220.35-0.390.610.430.290.48-0.57-0.370.650.520.480.620.460.620.620.10.39-0.420.10.310.46
0.350.850.87-0.110.69-0.930.720.34-0.010.94-0.960.270.780.520.870.770.350.770.62-0.380.62-0.65-0.380.480.97
0.310.941.0-0.210.54-0.830.880.30.070.83-0.90.170.650.480.870.650.310.650.48-0.230.52-0.54-0.230.730.87
0.630.530.630.290.85-0.710.660.620.310.81-0.79-0.120.990.620.770.650.631.00.71-0.370.65-0.68-0.370.160.62
1.00.10.280.860.73-0.120.441.00.220.31-0.38-0.610.680.460.350.310.630.630.750.26-0.170.130.260.330.27
0.630.530.630.290.85-0.710.660.620.310.81-0.79-0.120.990.620.770.651.00.630.71-0.370.65-0.68-0.370.160.62
0.750.270.480.510.58-0.510.640.740.130.67-0.7-0.190.710.620.620.480.710.750.71-0.130.14-0.19-0.130.310.58
0.26-0.25-0.230.43-0.240.66-0.160.260.12-0.60.44-0.77-0.230.1-0.38-0.23-0.370.26-0.37-0.13-0.630.631.00.26-0.31
-0.170.570.52-0.460.34-0.740.42-0.190.250.68-0.60.340.60.390.620.520.65-0.170.650.14-0.63-1.0-0.63-0.10.49
0.13-0.59-0.550.44-0.360.76-0.450.15-0.26-0.70.63-0.32-0.63-0.42-0.65-0.54-0.680.13-0.68-0.190.63-1.00.630.08-0.52
0.26-0.25-0.230.43-0.240.66-0.160.260.12-0.60.44-0.77-0.230.1-0.38-0.23-0.370.26-0.37-0.131.0-0.630.630.26-0.31
0.330.720.73-0.030.27-0.370.540.33-0.280.41-0.55-0.060.20.310.480.730.160.330.160.310.26-0.10.080.260.59
0.270.870.88-0.180.56-0.890.70.26-0.120.89-0.930.340.630.460.970.870.620.270.620.58-0.310.49-0.52-0.310.59
Click cells to compare fundamentals

Checkpoint Therapeutics Account Relationship Matchups

Checkpoint Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets27.0M42.6M55.7M13.3M5.4M5.1M
Other Current Liab4.2M3.8M9.8M21.2M11.9M6.3M
Total Current Liabilities8.1M7.2M26.0M32.8M18.4M12.9M
Total Stockholder Equity18.8M35.4M29.7M(19.5M)(13.0M)(12.4M)
Net Tangible Assets11.8M18.8M35.4M29.7M34.2M26.1M
Retained Earnings(120.1M)(143.2M)(199.9M)(262.5M)(314.3M)(298.6M)
Accounts Payable3.9M3.4M16.1M11.5M6.6M7.2M
Cash26.1M40.8M54.7M12.1M4.9M4.7M
Net Receivables26K20K17K73K65.7K62.4K
Common Stock Total Equity4K6K7K9K10.4K10.9K
Retained Earnings Total Equity(95.4M)(120.1M)(143.2M)(199.9M)(179.9M)(170.9M)
Common Stock Shares Outstanding3.5M5.6M7.6M8.8M18.7M19.7M
Other Current Assets863K1.8M976K1.1M450K427.5K
Other Stockholder Equity136.4M173.9M216.4M243.0M301.3M150.7M
Total Liab8.1M7.2M26.0M32.8M18.4M13.2M
Total Current Assets27.0M42.6M55.7M13.3M5.4M5.1M
Accumulated Other Comprehensive Income2.5M4.6M6.6M1.9M3.4M3.3M
Common Stock4K6K7K9K1K4.2K
Net Debt(26.1M)(40.8M)(54.7M)(12.1M)(4.9M)(5.2M)
Cash And Short Term Investments26.1M40.8M54.7M12.1M4.9M4.7M
Liabilities And Stockholders Equity27.0M42.6M55.7M13.3M5.4M5.1M
Capital Surpluse107.2M139.0M173.9M223.0M256.5M133.0M
Net Invested Capital18.8M35.4M29.7M(19.5M)(13.0M)(12.4M)
Net Working Capital18.8M35.4M29.7M(19.5M)(13.0M)(12.4M)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Checkpoint Stock Analysis

When running Checkpoint Therapeutics' price analysis, check to measure Checkpoint Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Checkpoint Therapeutics is operating at the current time. Most of Checkpoint Therapeutics' value examination focuses on studying past and present price action to predict the probability of Checkpoint Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Checkpoint Therapeutics' price. Additionally, you may evaluate how the addition of Checkpoint Therapeutics to your portfolios can decrease your overall portfolio volatility.